Althea Foster is one of the foremost podiatrists involved in the management of the diabetic foot.She belongs to Kings College London and has played a major role inpopularising basic foot care for diabetes.She conducted a comprehensive live workshop on management of the diabetic foot on July 15th, 2008.

Ajit Varki is currently Professor in the Departments of Medicine and Cellular & Molecular Medicine, Co-Director of the Glycobiology Research and Training Center, and Associate Dean for Physician-Scientist Training at the University of California, San Diego (UCSD). He received basic training in Physiology, Medicine, Biology, and Biochemistry at the Christian Medical College, Vellore, The University of Nebraska, and Washington University in St. Louis. He also has training and board certification in internal medicine, hematology, and oncology. Dr.Varki is Executive Editor of the textbook "Essentials of a MERIT award from the NIH, and an American Cancer Society Faculty Research Award. He is an elected member of the American Academy of Arts and Sciences, the American Society for Clinical Investigation, and the Association of American Physicians. Significant past appointments include: Co-Head, UCSD Division of Hematology-Oncology (1987-89); President of the Society for Glycobiology (1996); Editor-in-Chief of the Journal of Clinical Investigation (1992-97); Interim Directorship of the UCSD Cancer Center (1996-1997), and President of the American Society for Clinical Investigation (1998-1999). Dr. Varki's research interests are focused on a family of cell surface sugars called the Sialic Acids, and their roles in biology, evolution and disease. Currently active projects are relevant to the roles of sialic acids in microbial infectivity, the regulation of the immune response, the progression and spread of tumors, and, unique aspects of human evolution. His group is particularly intrigued in finding multiple differences in sialic acid biology between humans and our closest evolutionary cousins, the great apes. These differences are a signature of the events that occurred during the last few million years of human evolution, and appear relevant to understanding several aspects of the current human condition, both in health and disease. He visited the Department on January 2007.

Professor Boulton graduated (with honors) from the University of Newcastle-upon-Tyne Medical School. He was subsequently a research fellow under Professor JD Ward in Sheffield, and Visiting Assistant Professor at the University of Miami prior to accepting an appointment at the Manchester Royal Infirmary. Professor Boulton has authored more than 350 peer-reviewed manuscripts and book chapters,mainly on diabetic neuropathy and foot complications. He was the principal invited lecturer at the launch of the American Diabetes Association's Foot Care Council. Among his many awards, his contribution to worldwide care of the diabetic foot was honored by receiving the American Diabetes Association's Roger Pecoraro Lectureship, the EASD Camillo Golgi prize and was the first recipient of the international award on diabetic foot research.

He was the founding Chairman of the Diabetic Foot Study Group was previously Chairman of Postgraduate Education and then program chair for the European Association for the Study of Diabetes (EASD). He is currently director of extra-European postgraduate education and training for the EASD.

He visited the Department on January 2007.

Ashley Grossman initially graduated with a BA in Psychology and Social Anthropology from the University of London, then entered University College Hospital Medical School in London and took the University Gold Medal in 1975. He also obtained a BSc in Neuroscience.He joined the Department of Endocrinology at St. Bartholomew's Hospital where he spent most of his career, eventually as Professor of Neuroendocrinology,but has recently moved to become Professor ofEndocrinology at the University of Oxford in the Oxford Centre for Diabetes,Endocrinology and Metabolism.In2000 he was appointed a Fellow ofthe Academy of Medical Sciences. In 2011he was made a Fellow of Green­ Templeton College at the University of Oxford. He has published more than 700 research papers and reviews. He is immediate Past-President of the European Neuroendocrine Association (ENEA), Chairman of the UKI Neuroendocrine Tumour Society (UKINETS), Chairman of the European Neuroendocrine Society (ENETS) Advisory Board, and President for the Society of Endocrinology. He is past editor of the journal Clinical Endocrinology, on the editorial board of the major textbook De Groot and Jameson's Endocrinology,is Vice­ Chairman of the major on-line textbook Endotext.org,and serves on the editorialboards of many journals.

Bernd Scheithauer is a consultant in pathologist in the Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. A world renowned neuropathologist, Dr Scheithauer completed his training in Neuropathology from the Stanford University under the guidance of one of the pioneers in this field Luci J Rubinstein.

Dr Scheithauer joined Mayo College of Medicine in 1979 and has been one of the most respected members of the faculty of this reputed institution ever since.

His skillful diagnostic abilities stem from a keen eye for detail and a thorough understanding of neurobiology. His vast experience in Neuropathology makes him a walking atlas of different morphologic patterns that one can see in Neuropathology. A morphologist at heart BWS has not shunned the advances in molecular Neuropathology, but has found a good balance between the two, using information gathered from molecular tests on occasion to complement his interpretation of a case.

BWS is a passionate and superb teacher - the constant stream of visiting pathologist training under his guidance at Mayo are a testament to this fact. A prolific writer he has more than 600 articles, and more than 60 chapters on various topics related to Neuropathology to his credit. In addition he has edited and co-authored several textbooks in Neuropathology. His research interests are in the classification and pathobiology of brain, pituitary and peripheral nerve tumors. He visited the Department on January 2001.

01.08.2001- Chief Physician, Steno Diabetes Center, Gentofte, Denmark.

01.01.2005 – Adjunct Professor of Metabolism and Clinical Diabetes Research, Lund University, Sweden

Research Interest : Low Birth weight and foetal orgin of Diabetes and has over 100 Publications . He visited the Department on January 2007.

Current Position

Associate Professor, Karolinska Institute, Division of Diabetes and Endocrinology, Department of Molecular Medicine Head, Molecular Immunogenetics Group, Center for Molecular Medicine, Karolinska Hospital, Stockholm Karolinska Institute's Scientific Coordinator for India

Assignments

Member of the Council of European Association for the Study of Diabetes (EASD since 2003)

Member of the Genetics committee of the TRIAL NET of USA. Trialet is a network of individual scientists who work together in evaluating protocols and research plans submitted by various researchers for conduction human clinical trials for the Prevention of Type 1 diabetes, post diabetes prevention trial 1 (DPT-1).

Member of the Type 1 Diabetes Genetics Consortium (T1DGC) supported by NIH (USA) and JDRF (USA). The aim of the T1DGC is to collect T1DM families from all over the world for genome wide scanning of diabetes susceptibiity genes. I am in-charge of collecting families from South Asia. He visited the Department on September 2006.

Dr. Saudek graduated from Harvard College and Cornell University Medical College, training in metabolism at Boston City Hospital, Harvard Unit, followed by a fellowship in metabolism at Harvard Medical School. Dr. Saudek joined the faculty of Johns Hopkins University School of Medicine where he is currently the Hugh P. McCormick Family Professor of Medicine,

Director of the Johns Hopkins Diabetes Center and Program Director of the General Clinical Research Center. At Johns Hopkins, Dr. Saudek teaches students at all levels. He sees patients regularly, and lectures on various aspects of diabetes. He founded the Johns Hopkins Diabetes Center, a patient education program, and authored The Johns Hopkins Guide to Diabetes: for Today and Tomorrow (JHU Press). His research has focused on the development of the implantable insulin pump. He is principal investigator of the Hopkins center for the Diabetes Prevention Program (DPP), and of a Training Grant in Diabetes and Endocrinology, and other research grants. The NIH has continuously funded Dr. Saudek since 1975.

Dr. Saudek has been active in professional organizations, and was President of the American Diabetes Association in 2001-2, and named Outstanding Clinician in Diabetes by the ADA in 1990. He visited the Department on January 2007.

Professor Bernie Tuch is the Director of the Diabetes Transplant Unit at Prince of Wales Hospital and The University of New South Wales in Sydney, Australia. He is a senior staff specialist in endocrinology. His Unit is on the cutting edge of research into replacing the missing insulin-producing cells as a treatment of type 1 diabetes. Such treatments include novel approaches, such as placing insulin-producing cells from donor human pancreases inside capsules to prevent rejection when transplanted and creating human embryonic stem cells to differentiate them into insulin-producing cells. Support is forthcoming from national and international peer-reviewed grants, industry and private sources. Professor Tuch directs the New South Wales Stem Cell Network, a group of 500 professionals interested in stem cells and their applications.Internationally, he is a Councillor for the Cell Transplant Society. During the three decades of his research he has produced 126 manuscripts in refereed journals, written 11 book chapters and 1 book. He visited the Department on January 2007.

Consultant Endocrinologist

Fredrik Karpe is a Welcome Trust senior clinical research fellow and an honorary consultant physician at Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), Oxford UK. The focus of Dr Karpe's research is on human lipid and carbohydrate metabolism using integrative physiological and genomic approaches to understand the metabolic and cardiovascular complications of obesity and type 2 diabetes.

A particular interest is the development and adoption of techniques for tissue-specific study of metabolic and physiological processes in vivo in humans. This often involves stable isotope tracer studies in combination with genomic/genetic approaches, sometimes using pharmacological agents to investigate tissue-specific metabolism and functional studies of human adipose tissue in vivo. Some of these studies are enabled by the establishment of the Oxford Biobank, which is a population-based screening of healthy participants in Oxfordshire allowing for a "recruit-by-genotype" approach. Dr Karpe's research is funded by the Wellcome Trust, British Heart Foundation and Diabetes UK. Dr Karpe is a member of the editorial boards of three international journals: 1. Atherosclerosis, 2. Nutrition, Metabolism and Cardiovascular disease and 3. International Journal of Obesity. His is President-Elect for the Royal Society of Medicine section on Lipids in Clinical Medicine. He visited the Department on January 2006.

Dr. Chrousos is Professor and Chairman of Pediatrics at the Athens University Medical School. He has focused his research on the hypothalamic-pituitary-adrenal (HPA) axis and has extensively studied the neuroendocrine alterations associated with mood disorders, sleep, pain perception, and immune function.

His laboratory is recognized worldwide for its work on the glucocorticoid signaling system, diseases of the HPA axis, such as Cushing’s syndrome, and the physiologic and molecular mechanisms of stress. Dr. Chrousos has contributed immensely to the biomedical literature and his work has provided new insights into a variety of chronic complex disorders. He has written over 1000 scientific papers and his work has been cited in over 40,000 other scientific articles, an irrefutable testimony to the importance and influence of his research. He is one of the most cited physician scientists in the world (ISI highly cited) both in Clinical Medicine and in Biology and Biochemistry. His work has educated a broad community of physicians and scientists around the world. As a mentor, he has helped to develop the careers of many young physicians and scientists, several of whom are now professors and chairpersons in Europe, the United States, Australia and Latin America. An oustanding teacher, he has had a number of visiting professorships and given prestigious lectures throughout the world. Dr. Chrousos has received numerous national and international awards for his work, including election to membership in the prestigious American Society of Clinical Investigation and the Association of American Physicians. He was recently inducted as a master of both the American College of Endocrinology and the American College of Physicians. He visited the Department on January 2007.

Dr. Mukherjee is a Consultant Endocrinologist in the Department of Medicine at the National University Hospital (NUH), Singapore and a Clinical Lecturer in the Faculty of Medicine, National University of Singapore. His chief clinical interests are in pituitary & adrenal disorders, endocrine hypertension, and neuroendocrine tumours. He is in the specialist advisory panel of the Annals, Academy of Medicine, Singapore, is an active member of a number of administrative committees in NUH, and is an executive committee member of the Endocrine and Metabolic Society of Singapore. He visited the Department on January 2007.

Dr Iskandar Idris is a Consultant in Diabetes, Endocrinology and Internal medicine for the Sherwood Forest Hospitals NHS Trust, UK.

Dr Idris is currently a member of the EASD-Hypertension in Diabetes Study group, and is also in the steering committee for the implementation of the North Nottinghamshire Diabetic Retinopathy screening programme.

His current research interests are in cardiovascular risks in patients with diabetes, the metabolic syndrome and pharmacological treatment for hyperglycaemia and vascular complications of diabetes. He has published widely in the field of diabetes and vascular complications. He visited the Department on January 2007.

Kalman Kovacs obtained his MD degree from the Medical University of Szeged, Szeged, Hungary. As a medical student, he started to be involved in research in the Department of Pathology, University of Szeged. After graduating, he continued to work at the same department and performed research, autopsy and surgical pathology. After a few years, he moved to the Department of Medicine and was trained as a clinical endocrinologist. He received a fellowship from the University of Liverpool, Liverpool, England. Under the supervision of Dr. H.L. Sheehan, a world renowned and respected scientist and pathologist, he received his Ph.D. degree. In 1968 he was invited to Canada as a visiting scientist to carry out research at the Department of Experimental Medicine and Surgery, University of Montreal. The Department Head was Dr. H. Selye, a superb researcher. In 1971, Dr. Kovacs moved to Toronto and as a staff pathologist, worked at the Department of Pathology, St. Michael’s Hospital, a major teaching hospital of the University of Toronto. In 1980, he was promoted to the rank of Professor of Pathology.

Dr. Kovacs’ main interest is endocrine pathology, primarily pathology of the pituitary gland and its tumours. He has published many papers, book chapters and books. He is the founding editor of the journal: Endocrine Pathology. He is an editorial board member of several journals and associate editor of the journal: Pituitary. He is a member of the Canadian, American and British Pathology Societies. He has lectured at many local, national and international meetings, chaired sessions and organized several symposia. Dr. Kovacs has received several awards, has supervised many students, researchers and post-doctoral fellows.

His contributions are internationally recognized and respected, making him a leader in pituitary pathology. He visited the Department on January 2001.

Professor K O Lee is Professor and Head of Endocrinology at the Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, and National University Hospital, Singapore. He graduated in Medicine from the Queen's University of Belfast, Northern Ireland and eventually came to work in the National University in Singapore. In addition to his training in Belfast, he has spent time at the National Institutes of Health in Bethesda, and at Stanford University.

His primary research focus is on the growth hormone (GH) - insulin like growth factor (IGF)- IGF binding protein axis; but has clinical responsibilities as Head of Endocrinology in most of the other areas of Non-Diabetes endocrinology at the National University Hospital. He has published 80 papers in peer-reviewed journals.

His previous administrative and Professional positions include - President of the Endocrine and Metabolic Society of Singapore, Chairman of the Chapter of Physicians in the Academy of Medicine, Singapore, and Chairman of the Endocrinology Advanced Training Committee in Singapore. He is an Editor of the J AFES (Journal of the ASEAN Federation of Endocrine Societies) and Review of Endocrinology. He visited the Department on January 2007.

Dr Marie-France Kong is a consultant in Diabetes & Endocrinology at the University Hospitals of Leicester, United Kingdom. She graduated from Aberdeen medical school and did her postgraduate training in the West Midlands and in Nottingham. She did her research on "gastric emptying and glycaemic control in diabetes mellitus" in Nottingham with Professors Tattersall and Macdonald and in Adelaide, South Australia, with Professor Michael Horowitz. Other research interests include pregnancy and diabetes, complications of diabetes and cardiometabolic syndrome. Dr. Kong is a contributing editor for the Continuing Education section of Diabetic Medicine. She visited the Department on January 2007.

Dr. Prakash Abraham completed his undergraduate (batch of 1985) & postgraduate (1993-96) medical education in Christian Medical College & Hospital,Vellore,India. He completed his higher specialist training in Diabetes and Endocrinology in Aberdeen (Scotland) in 2002. He has subsequently been working as a Consultant Endocrinologist at the Aberdeen Royal Infirmary (and Honorary Senior Lecturer atthe University of Aberdeen). He has an interest in clinical thyroid disease and has several publications in the field including two systematic reviews relating to the therapy of hyperthyroidism. He has been a member of the executive committee of the British Thyroid Association between 2003-2009 serving 2 years as the assistant secretary and 3 years as the secretary of the Association. He has been on the programmeorganising committee of the UK Society for Endocrinology for 3 years until2009. In Diabetes he is the local lead for insulin pump therapy. He is a member of the Scottish Diabetes Research network and is active in facilitating commercial and academic clinical trials in Aberdeen. He is the local principal investigator for several multicenter diabetes clinical trials.

Prof Michael Horowitz was appointed to a Personal Chair at the University of Adelaide in 1995, and has been the Director of the Endocrine and Metabolic Unit at the Royal Adelaide Hospital since 1997. His research activities are almost exclusively clinically-based and relate primarily to gastrointestinal motor, sensory, and hormonal function, particularly in the context of diabetes mellitus, glycaemic control, and appetite regulation. Prof Horowitz is a co-author of 401 peer-reviewed papers and 32 book chapters, placing him in the top 1% of cited authors in clinical medicine world-wide. He is co-editor (with Prof Melvin Samsom) of a multi-author book entitled ‘Gastrointestinal function in diabetes mellitus’, published in 2004, which represents the most comprehensive treatise on this subject. Prof Horowitz has had extensive involvement as an invited speaker at international and scientific meetings, including the annual meetings of the American Diabetes Association, American Gastroenterological Association, European Association for the Study of Diabetes and American Motility Society. The insights derived from his work have been of fundamental relevance to the management of diabetes in the spheres of both prevention and treatment. He has been the recipient of a number of awards, including the Elder Prize for Scholarship at the University of Adelaide in 1995, the Distinguished Research Prize of the Gastroenterological Society of Australia (1999), and the Eric Susman Prize of the Royal Australasian College of Physicians (2000). Prof Horowitz has supervised 29 PhD or MD candidates from medical, science, nuclear medicine, nursing and dietetic backgrounds, and 11 postdoctoral research fellows (from the UK, the Netherlands, Germany, and Singapore). He visited the Department on January 2007.

Dr. Noel Somasundaram is a Chief Consultant Endocrinologist,National Hospital of Sri Lanka. He passed out of University of Jaffna, Sri Lanka with distinctions in Parasitology, Forensic Medicine, Pharmacology, Community Medicine, Medicine and Gynaecology and Obstetrics. He was the best outgoing from the university with8 awards for excellence and was placed second in the national ranking scheme. His subsequent postgraduate studies were from University of Colombo and he obtained MD in 2000 with best overall performance. He underwent training in Endocrinology at Endocrine Institute, Queen Mary College, University Of London,Clinical Work as Specialist Registrar (2002-2004) at St Bartholomew's Hospital, London. He is the first board certified endocrinologist of Sri Lanka and is Chief Consultant Endocrinologist, National Hospital of Sri Lanka. He is also the chief trainer for post graduate trainees in endocrinology. He is the President of the Endocrine Society of Sri Lanka. His publications include thyroid disease, nonalcoholic fatty liver disease, difficult to control diabetes.

(Professor of Diabetic Medicine, Diabetes Trials Unit, The Oxford Centre for Diabetes, Endocrinology and Metabolism)

Rury Holman is Professor of Diabetic Medicine at the University of Oxford, Academic Chairman of the Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), Director of the Diabetes Trials Unit, and an Honorary Consultant Physician to the Oxford Radcliffe Hospitals Trust. He was the 2002 Pfizer Visiting Professor at the University of Washington, gave the 2003 Lord Rayner Memorial Lecture and was awarded the 2006 Hellmut Mehnert Award. He divides his time between the clinical care of patients, teaching and his many research interests. He has designed and run many multicentre studies that focus primarily on the prevention and appropriate treatment of Type 2 diabetes. Professor Holman, who is asked frequently to speak at international meetings, has published over 250 peer-reviewed papers, is co-chair of the NAVIGATOR and DREAM trials and principal investigator of AFORRD, 4-T and the UK Prospective Diabetes Study (UKPDS). He visited the Department on January 2007.

• Evidence based systems and standards of diabetes care
• Guideline implementation and models of diabetes care
• Screening for Type 2 diabetes
• Economic aspects of diabetes. He visited the Department on January 2002.

Professor Chatterjee graduated from Cambridge and completed his clinical training at Oxford Medical School. He trained as an Endocrinologist at the Hammersmith Hospital, London and subsequently conducted research in the Thyroid Unit at Massachusetts General Hospital, Boston. In 1990, he returned to the Department of Medicine in Cambridge and was appointed Professor of Endocrinology in 1998. His research interests include nuclear hormone receptors (thyroid, PPAR?) and human disease, genetic thyroid disorders and hormone replacement in adrenal insufficiency. He visited the Department on January 2007.

Professor Bruno Carnaille graduated in 1978 from the Lille school of Medicine, followed by residency in surgery completed in 1984.Currently he is the professor of surgery at the Department of General and Endocrine surgery at the LilleUniversity Hospital. He is also awarded the International Scholar of the American College Of Surgeons in1997. He is also a member of the Francophone, British,European,American and International Associations of Endocrine Surgeons.

Dr. Kebebew received his bachelor's degree from the University of California,Los Angeles in Chemical Engineering. He completed his medical training, surgical residency and NCIT32 Surgical Oncology Basic Science fellowship at the University of California, San Francisco. Dr. Kebebewjoined the surgical faculty at the University of California,San Francisco in 2002.In 2009,Dr. Kebebew was recruitedto be the Head of the Endocrine Oncology Section in the Surgery Branch,Center for Cancer Research at the National Cancer Institute, Bethesda, M.D. In 2012, he became chief of the newly established Endocrine Oncology Branch.

Dr. Chen currently holds the Layton F. Rikkers MD Chair in Surgical Leadership and is Division Chairman of General Surgeryat the University of Wisconsin. He is also the Vice Chair of the Department of Surgery, Professor of Surgery and Biomedical Engineering, and the Leader of the Endocrine-Neuroendocrine Cancer Disease Group at the University of Wisconsin Carbone Cancer Center. His clinical interests include endocrine and neuroendocrine disease with a focus on minimally invasiveendocrine surgery. Dr. Chen's lab studies the role of Notch signaling in thyroid and neuroendocrine cancers.

Dr. Henry N.Rajaratnam. M.D. (Cey), M.R.C.P. (UK), F.R.C.P. (Lend), F.C.C.P., Hen F.R.A.C.P. and F.A.C.E. The President of the Ceylon College of Physicians 1996. The President of the Endocrine Society of Sri Lanka 1993 2003. Patron of the Endocrine Society of Sri Lanka 2006 to date. Compiler of the Endocrine Update of theEndocrine Society of Sri Lanka 1994 to date. Compiler of the Medicine Update for the Ceylon College of Physicians 1992 to date. Has published many articles in International and National journals. Presented papers at many National conferences. Lectured both Nationally and Internationally in India, Malaysia, Myanmar, Indonesia and Pakistan. He is the pioneer Endocrinologist of Sri Lanka and his main interests are in Autoimmune Thyroiditis, Thyroid Hormone resistance, Snake bite and pituitary disease and diabetes.

Prof. Khalid Hussain is a Reader/Honorary Consultant Paediatric Endocrinologist Great Ormond Street Children's Hospital London UK. Neonatology/Metabolism and Paediatric Endocrinology in London. He works in the Clinical and Molecular Genetics Unit Institute of Child Health, University College London UK. He has 170 peer reviewed articles and 5 text book chapters to his credit.

Dr. Nipun Merchant received his undergraduate degree in Biology from New York University. He earned his medical degree from State University of New York where he graduated Cum Laude and was elected to the Alpha Omega Alpha Honor Society. He completed his General Surgery residency at Temple University Hospital in Philadelphia. He then completed a fellowship in Surgical Oncology at Memorial Sloan-Kettering Cancer Center in New York. After completion of his fellowship, Dr. Merchant was on faculty at Johns Hopkins University Medical School as an Assistant Professor of Surgery and on staff at Sinai Hospital of Baltimore. Dr. Merchant is currently Professor of Surgery and Cancer Biology at Vanderbilt University Medical Center. He is the Chief of the Section of Gl Surgical Oncology in the Department of Surgery,the Co-Leader of the Gl Oncology Program at the Vanderbilt-Ingram Cancer Center and the Director of the Vanderbilt Pancreas Center. Dr. Merchant is board certified by the American Board of Surgery,is a Governor of the American College of Surgeons,a member of the Commission on Cancer and serves on the Pancreas Cancer Panel of the National Comprehensive Cancer Network {NCCN) and the Pancreas Cancer Task Force of the National Cancer Institute {NCI). He belongs to numerous societies in which he serves in leadership roles and is on the Editorial Board of several journals.

Dr Roderick John CLIFTON-BLIGH is currently the Staff Specialist in Endocrinology, Department of Endocrinology Royal North Shore Hospital,StLeonards,Associate Professor in Medicine (conjoint), University of Sydney. He has completed his Bsc (med) Hons at the University of Sydney in1990, followed by MBBS Hons I andUniversity Medal, University of Sydney in1993, further he completed his PhD from the University of Cambridge, UK in 1999 and FRACP - Royal Australasian College of Physicians in 2004 and FFSc (RCPA) Royal College of Pathologists of Australasia 2011. He has several research grants, awards, book chapters and publications to his credit. He is a dedicated member of his profession and specialty (Endocrinology) and has been a member of the Specialist Advisory Committee in Endocrinology at the Royal Australasian College of Physicians (RACP) since 2004, which credentials Advanced Trainees in Endocrinology Australasia-wide, and accredits settings of training (Endocrine Units in major teaching hospitals).

Dr. RathanSubramaniam is a full time active staff nuclear medicine physician and a radiologist and an Associate Professor in the division of nuclear medicine, Russell H Morgan department of Radiology and Radiological Sciences at the Johns Hopkins University School of Medicine, Baltimore, MD. He is an international authority in molecular imaging with PET/CT. He is also a sub-specialty board certified neuroradiologist and diagnostic radiologist by the American Board of Radiology and a fellow of the Royal Australian and New Zealand College of Radiologists. He is a visiting faculty at the University of Perdana Johns Hopkins Graduate School of Medicine, Malaysia, a clinical faculty at the Tawam Molecular Imaging Center (Johns Hopkins International),UAEand an adjunct associate professor of radiology at the Boston University School of Medicine, Boston, MA. He is lectures at the American Institute of Radiologic Pathology (AIRP). He is the President of Radiology Research Alliance, the Vice Chair of American College of Radiology commission on Molecular imaging and nuclear medicine, the secretary of the Maryland Radiological Society, the secretary of the American College of Nuclear Medicine, a board member of nuclear oncology council of the Society of Nuclear Medicine, a life member of the Fulbright Academy and a member of the Royal Society of New Zealand and New Zealand Fulbright Association.

Dr.Kjell Oberg is Professor of Endocrine Oncology at the Medical Faculty of Uppsala University. He was the former head of the Department of Endocrine Oncology, University Hospital, and he is a specialist in endocrinology and internal medicine. He founded the Dept. Of Endocrine Oncology at Uppsala University Hospital and has30 years’ experience in the field of neuroendocrine tumors. Between 1986 and 1992 he was clinical associate director of the Ludwig Institute for Cancer Research. From 1998 to 2002 he was chairman of the Department of Medical Sciences at the Medical Faculty of Uppsala University. Since July 2002 until June 2008 he has been the Dean of the Medical Faculty.He is the chairman of Centre of Excellence of Endocrine Tumors and Vice chairman of the Department of Endocrine Oncology,UniversityHospital,Uppsala. Currently Adjunct Professor of Surgery at Vanderbilt University, Nashville, US. Dr. Oberg is a member of the Royal Society of Sciences, member of Swedish Society of MedicalResearch,Honorary member of Finnish Oncology Society, Finnish Endocrine Society and Honorary member of Spanish Neuroendocrine NET-work.Dr.Oberg is President of ENETS since March 2012 and also a member of NANETS Advisory Board as well as several other national and international research and scientific boards and many scientific journal review boards.

He joined the University of Sheffield In 2001asa Clinical Research Lecturer In SurgicalOncoiOBY and was involved in the "Sheffield Breast Cancer Study" looking at low penetrance aenespredlsposlna to susceptibility and severity of breast cancer. He completed his PhD and stayed with the University as Clinical Lecturer and Honorary Specialist Registrar in General Surgery till he completed his clinical training in General surgery and Endocrine surgery In 200!1. He then did a Fellowship in Endocrine Surgery in King's College Hospital, London. He then returned to work In Sheffield In 2010 and is currently NIHR funded Academic Senior Clinical lecturer from 2010.

His research Interests are Investigation of the roleofSentinel Node Biopsy In Thyroid Cancer andIts application In clinical practice, Epidemiology and causation of Su11ical Endocrine Disease (of the thyroid, parathyroid, adrenal and pancreas),investigating the evidence base for the surgical management of Thyroid and Parathyroid disease and exploring new treatment strategies.

Stan Sidhuis Professor of Surgery in the University of Sydney Endoaine Su1Jical Unit. He has one of thelaraest pure EndocrineSurgical practices in Australia and is responsible fortralnlng local andoverseas Endocrine Surgeons In Fellowship positions based at Hornsby and RoyaiNorthShoreHospitals. He is President of Australian Endocrine surgeons and the first Australian surgeon ever appointed to the Editorial Board oftheAnnals of Surgery.He has been a dlnlcal and translational researcher for over 10 years. His research hasfocused on clinical outcome studies and translational cancer research in thyroid, parathyroid and adrenal tumours. He has made significant contributions to the understanding of the oncogenomlcs of adrenocortical cancer and the use of microRNAs as diagnostic, prosnostic and therapeutic ta11ets In adrenocortical cancer. maltsnantpheochromocytoma and thyroid cancer. Most recentl'6 hehascontributed totheeme11insfield of miRNA regulation of autophagy in medullary thyroid cancer. He Isengaged In a collaboration with a biotechnology firm EngeneiC who hold several patents over a unique cancer cell targeted In vivo nanopartlcle delivery system. He has supervised 9doctoral students and 2 postdoctoral scientists. He is a former NSW Cancer Institute Research Fellow leading national adrenal cancer consortium to find better ways to treat this difficult disease. In the last decade he has presented at a number of local and lnternatlonal clinical and scientific meetings and is currently the author or co-author of over130publicationsinpeer reviewed journals and book chapters.